WO/2008/030579 is referenced by 31 patents.

The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase, such as rheumatoid arthitis, multiple sclerosis, sepsis, osteoarthrites, inflammatory bowel disease, osteoporosis, myasthenia gravis, stroke, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, psoriasis, cardiac contractile dysfunction, type I diabetes, type II diabetes, familial cold autoinf lammatory syndrome, severe bacterial infections, allergic disease, cancer, psoriasis, asthma, or graft rejection.

Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
Application Number
Publication Number
Application Date
September 7, 2007
Publication Date
March 13, 2008
Chin Donovan
Hammond Charles
Jewell Charles
Durand Reville Thomas
O BRIEN Jonathan P
Chin Donovan
Hammond Charles
Jewell Charles
Durand Reville Thomas
Biogen Idec Ma
C07D 487/04
A61P 09/04
A61P 31/04
A61P 03/10
A61P 25/28
A61P 25/02
A61P 17/06
A61P 01/00
A61K 31/5025
A61P 19/02
View Original Source